American Renal Associates Holdings Revenue, Profits - ARA Quarterly Income Statement

Add to My Stocks
$20.24 $0.3 (1.5%) ARA stock closing price Sep 18, 2018 (Closing)

Financial analysis of American Renal Associates Holdings involves more than just checking the American Renal Associates Holdings stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the ARA income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue growth of 11.56% when compared to the same period in the past. Along with American Renal Associates Holdings assets and American Renal Associates Holdings free cash flow, American Renal Associates Holdings profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $-18.01M and the 2018 Q2 revenue is $217.18M.

View and download details of revenue and profits for American Renal Associates Holdings for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
American Renal Associates Holdings Revenues or Net Sales
217.18M194.67M194.38M187.71M185.99M177.03M199.11M192.96M186.94M172.13M
Cost Of Goods Sold (COGS)140.56M133.73M124.51M119.59M118.05M120.3M121.17M116.11M109.71M105.45M
American Renal Associates Holdings Gross Profit
76.62M60.94M69.89M68.11M67.93M56.72M77.96M76.84M75.84M66.67M
Research & Development Expense----------
Selling General & Admin Expense59.35M29.91M26.22M25.77M31.39M35.18M43.86M37.4M33.86M21.52M
Income Before Depreciation Depletion Amortization17.27M31.02M43.69M42.33M36.53M21.54M34.1M39.43M41.98M45.15M
Depreciation Depletion Amortization9.81M9.62M9.75M9.43M9.38M9.07M9.26M8.68M8.25M7.67M
Non Operating Income1.74M-1.02M1.77M3.58M-3.16M4.51M-3.44M12.56M-12.54M-
Interest Expense8.13M7.45M7.25M7.25M7.18M7.6M7.37M7.37M8.94M12.25M
American Renal Associates Holdings Pretax Income
1.06M12.92M28.47M29.23M16.8M9.37M14.06M35.94M12.24M25.21M
Provision for Income Taxes-1.22M-0.79M8.75M2.55M--3.52M-2.17M-0.1M-1.14M2.66M
MinorityInterest20.29M14.62M19.5M18.68M18.49M14.15M23.69M23.62M22.48M18.8M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations2.28M-0.33M1.56M7.98M-4.63M-12.33M-7.12M12.42M-9.09M3.76M
Extraordinary Items & Discontinued Operations----------
American Renal Associates Holdings Profit/ Loss (Net Income)
-18.01M-0.33M1.56M7.98M-4.63M-12.33M-7.12M12.42M-9.09M3.76M
Average Shares used to compute Diluted EPS31.93M31.8M34.02M33.83M30.99M30.91M30.89M31.44M28.41M22.79M
Average Shares used to compute Basic EPS31.93M31.8M31.56M31.1M30.99M30.91M30.89M30.87M28.41M22.21M
Income Before Nonrecurring Items6.91M3.78M5.98M6.44M5.56M1.87M8.74M9.35M8.3M3.76M
Income from Nonrecurring Items-24.92M-4.11M-4.42M1.55M-10.19M-14.2M-15.86M3.07M-17.39M-
American Renal Associates Holdings Earnings Per Share Basic Net
-0.59-0.010.050.26-0.15-0.40-0.020.35-0.750.17
American Renal Associates Holdings Earnings Per Share Diluted Net
-0.59-0.010.050.24-0.15-0.40-0.020.34-0.750.16
EPS Diluted Before Nonrecurring Items0.200.110.180.190.160.060.260.280.260.16
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing American Renal Associates Holdings stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $217.18M for this quarter of 2018 Q2. Our American Renal Associates Holdings revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-18.01M for American Renal Associates Holdings for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The ARA financials along with American Renal Associates Holdings historical stock prices provide a lot of details about the firm.

American Renal Associates Holdings Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
0.81
Operating Margin
3.4
Dividend Yield
0%

Other Income Statements - American Renal Associates Holdings Inc Industry Peers

BioScrip income statement, HANGER INC income statement, RadNet income statement